BackDicerna Pharmaceuticals Overview

Dicerna Pharmaceuticals Gross Profit

Gross Profit analysis for DRNA.

Quarterly Gross Profit

$62.95M
↑ 28.81% YoY

As of Sep 30, 2021

Annual Gross Profit (TTM)

$192.85M
↑ 47.86% YoY

Trailing 12 months ending Sep 30, 2021

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin